Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page now presents details for the APG-115 trial, including its design, participant criteria, treatment arms, outcome measures, and participating sites. It also identifies the study as active but not recruiting.
    Difference
    58%
    Check dated 2026-11-09T13:44:05.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:54:54.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH updates and FAQs about replacing “Artificial Intelligence” with “Super Intelligence” terminology during a transition. The study record itself remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-26T14:52:50.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:43:17.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:48:06.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to indicate a new version of the study record. A broad set of study metadata items, including FDA-regulated status, IPD sharing, and location/investigator terms, were removed from the page.
    Difference
    18%
    Check dated 2026-09-21T22:45:34.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.